The combined effect of furosemide and propranolol on GSH homeostasis in ACHN renal cells

Toxicology Mechanisms and Methods

Volumn 24, Issue 6, 2014, Pages 412-416

  Zal, Fatemeh ^a,b   Taheri, Raheleh ^c   Khademi, Fatemeh ^c   Keshavarz, Ehsan ^d   Rajabi, Sadegh ^c   Mostafavi Pour, Zohreh ^c,e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACHN cell line; Furosemide; Glutathione homeostasis; Propranolol

Indexed keywords

FUROSEMIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMAN CELL; KIDNEY CELL; MTT ASSAY; PRIORITY JOURNAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM;

ADRENERGIC BETA-ANTAGONISTS; CELL LINE; DIURETICS; DRUG THERAPY, COMBINATION; FIBROBLASTS; FUROSEMIDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HOMEOSTASIS; HUMANS; KIDNEY; MOLECULAR STRUCTURE; PROPRANOLOL;

EID: 84906265304     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2014.926437     Document Type: Article

References (27)

1. Dickens FB, Weglicki WB, Boehme PA, Mak TI. (2002). Antioxidant and lysosomotropic properties of acridine-propranolol: Protection against oxidative endothelial cell injury. J Mol Cell Cardiol 34: 129-37.
2. El-Saharty SY. (2003). Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study. J Pharm Biomed Anal 33:699-709.
3. Ellman LG. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-7.
4. Espinosa Bosch M, Ruiz Sánchez AJ, Sánchez Rojas F, Bosch Ojeda C. (2008). Recent developments in analytical determination of furosemide. J Pharm Biomed Anal 48:519-32.
5. Fecondo VJ and Augusteyn RC. (1983). Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp Eye Res 36:15-23.
6. Gammella E, Leuenberger C, Gassmann M, Ostergaard L. (2013). Evidence of synergistic/additive effects of sildenafil and erythropoietin in enhancing survival and migration of hypoxic endothelial cells. Am J Physiol-Lung Cell Mol Physiol 304:L230-9.
7. Glantzounis KG, Salacinski HJ, Yang W, et al. (2005). The contemporary role of antioxidant therapy in attenuating liver ischemiareperfusion injury: A review. Liver Transplant 11:1031-47.
8. Guan S, Tee W, Ng D, et al. (2013). Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol 168:1707-18.
9. Hayes DJ, McLellan LI. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radical Res 31:273-300.
10. Jin Y, Pan X, Fu Z. (2012). Exposure to bifenthrin causes immunotoxicity and oxidative stress in male mice. Environ Toxico. [Epub ahead of print]. DOI: 10.1002/tox.21829.
11. Kastelova A, Dimova S, Nemery B. (2003). Propranolol cytotoxicity in rat and human lung in vitro. Methods Find Exp Clin Pharmacol 25: 509-15.
12. Lahet JJ, Lenfant F, Courderot-Masuyer C, et al. (2003). In vivo and in vitro antioxidant properties of furosemide. Life Sci 73: 1075-82.
13. Maiani G, Mobarhan S, Nicastro A, et al. (1983). Determination of glutathione reductase activity in erythrocytes and whole blood as an indicator of riboflavin nutrition. Acta Vitaminol Enzymol 5: 171-8.
14. Mak TI, Chmielinska JJ, Nedelec L, et al. (2006). D-propranolol attenuates lysosomal iron accumulation and oxidative injury in endothelial cells. J Pharmacol Exp Ther 317:522-8.
15. Mak TI, Weglicki WB. (1988). Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circulation Res 63:262-6.
16. Mak TI, Weglicki WB. (2004). Potent antioxidant properties of 4-hydroxyl-propranolol. J Pharmacol Exp Ther 308:85-90.
17. Masella RR, Di Benedetto R, Var?̀ R, et al. (2005). Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16: 577-86.
18. Meister A, Anderson ME. (1983). Glutathione. Annu Rev Biochem 52: 711-60.
19. Mosmanne T. (1983). Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-65.
20. Mostafavi-Pour Z, Zal F, Monabati A, Vessal M. (2008). Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatol Res 38:385-92.
21. Nies AS. (1990). Propranolol. Part II: non-cardioselective betaadrenoreceptor blockers. In Messerli FH, ed. Cardiovascular drug therapy. Philadelphia: Saunders Company, 420-41.
22. Powers KS, Lennon SL. (1999). Analysis of cellular responses to free radicals: Focus on exercise and skeletal muscle. Proceedings-Nutrition Society of London, Cambridge Univ Press.
23. Qin Y, Li L, Chen J, et al. (2012). Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitro. Oncol Res 20:61-9.
24. Rajamanikandan S, Sindhu T, Durgapriya D, et al. (2012). Protective effect of Mollugo nudicaulis Lam. on acute liver injury induced by perchloroethylene in experimental rats. Asian Pacific J Tropical Med 5:862-7.
25. Rezzani R. (2006). Exploring cyclosporine A-side effects and the protective role-played by antioxidants: The morphological and immunohistochemical studies. Histol Histopathol 21:301-16.
26. Weglicki W, Mak I, Sim̀c M. (1990). Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 22:1199-208.
27. Williams DP, Antoine DJ, Butler PJ, et al. (2007). The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: A chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322:1208-20.-baba ^^Pharmaceutical research center-baba ^^Shiraz University of Medical Sciences-baba-info The authors do not have any conflict of interest. This paper has been extracted from the thesis of Ehsan Keshavarz and was supported by Grant Number 90-3465 from Pharmaceutical research center and Vice-chancellor for Research Affairs of Shiraz University of Medical Sciences.